Pregabalin for Postoperative Pain in Women Undergoing Breast Cancer Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Postoperative Pain
Interventions
DRUG

Placebo

Lactulose Placebo

DRUG

Pregabalin 150 mg

150 mg Q12H x 2 doses

Trial Locations (1)

B3K 6R8

IWK Health Centre, Halifax

Sponsors

Lead Sponsor

All Listed Sponsors
lead

IWK Health Centre

OTHER

NCT00785382 - Pregabalin for Postoperative Pain in Women Undergoing Breast Cancer Surgery | Biotech Hunter | Biotech Hunter